Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127153) titled 'Real-World Study of the BV-ICE Regimen in Relapsed/Refractory Classical Hodgkin Lymphoma' on June 25.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Condition: Relapsed/refractory classical Hodgkin lymphoma

Intervention: PR before BV-ICE

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-01

Target Sample Size: PR before BV-ICE;non-PR before BV-ICE:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=320216

Published by HT Digit...